• Explore /
  • Poster
  • / Interim results of a phase Ib single-center study of pembrolizumab in combination with chemotherapy in patients with locally advanced or metastatic small cell/neuroendocrine cancers of the prostate and urothelium.

Interim results of a phase Ib single-center study of pembrolizumab in combination with chemotherapy in patients with locally advanced or metastatic small cell/neuroendocrine cancers of the prostate and urothelium.

Abstract Poster

Authors

null

Arnold I. Chin

Department of Urology, University of California, Los Angeles, Los Angeles, CA

Arnold I. Chin , Alexandra Drakaki , Sara Rodriguez , Ankush Sachadeva , Margaret Bradley , Nazy Zomorodian , Hanwei Zhang , Shanpeng Li , Gang Li , Matthew Rettig , Sandy Liu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03582475

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 510)

DOI

10.1200/JCO.2022.40.6_suppl.510

Abstract #

510

Poster Bd #

F12

Abstract Disclosures

Similar Posters

First Author: Arnold I. Chin

First Author: Robert A. Ramirez

First Author: Amin Nassar

First Author: Evan Y. Yu